Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Bennett D - The Caverject Impulse Dual Chamber System, a device used to deliver alprostadil for the treatment of erectile dysfunction, will return to pharmacy shelves following a months-long withdrawal. Alprostadil (prostaglandin E1 [PGE1]) is the main ingredient in Caverject. While oral phosphodiesterase type-5 (PDE-5) inhibitors have become popular during the last several years, alprostadil injections may be the only option for men who are taking nitrates, which may cause an adverse interaction with PDE-5 inhibitors.

Related Articles

Hormonal Testing and Pharmacologic Treatment of Erectile Dysfunction: A Clinical Practice Guideline From the American College of Physicians
Annals of Internal Medicine, 10/30/09    Relevance Score: 70%

Effects of 12-Month Tadalafil Therapy for Erectile Dysfunction on Couple Relationships: Results from the DETECT Study
The Journal of Sexual Medicine, 10/28/09    Relevance Score: 69%

Evaluation of Microalbuminuria in Patients with Erectile Dysfunction
The Journal of Sexual Medicine, 10/07/09    Relevance Score: 69%

New Drug Udenafil for Erectile Dysfunction in US Trials
Internet Source, 11/10/09    Relevance Score: 68%

The Association of Serum Prolidase Activity and Erectile Dysfunction
Journal of Andrology, 10/23/09    Relevance Score: 68%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address